[opensourcepharma] Coverage of Open Source Approaches to Drug Disc/Dev

[Matthew Todd]

All,

Lots of well-written coverage today of the work many of us are doing in a
special issue of Nature Outlook
<http://www.nature.com/nature/outlook/open-innovation/> and, by
coincidence, in The Lancet
<http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2816%2930518-9/abstract>
.

Also, in case you missed it, Alice Williamson, who works with me here in
Sydney on Open Source Malaria, won a competition to make a radio show, in
which she describes OSM and other open science issues. You can listen to it
on Radio National here
<http://www.abc.net.au/radionational/programs/scienceshow/open-source-removes-the-secrecy-in-drug-research/7390322>
.

Please remember - this public list is open to all to post directly, so if
you've items you think are of interest, please go right ahead and post (by
emailing opensourcepharma at lists.okfn.org). I liked this recent item
<http://www.law.utoronto.ca/news/law-students-redefine-patent-laws-in-clinic-program-structural-genomics-consortium>
on an initiative involving the SGC seeking new legal approaches towards
MTAs suitable for open projects.

Best wishes everyone,

Mat


-- 
MATTHEW TODD | Associate Professor
School of Chemistry | Faculty of Science

THE UNIVERSITY OF SYDNEY
Rm 519, F11 | The University of Sydney | NSW | 2006
T +61 2 9351 2180  | F +61 2 9351 3329  | M +61 415 274104
E matthew.todd at sydney.edu.au | W
http://sydney.edu.au/science/people/matthew.todd.php
W http://opensourcemalaria.org/ | W http://opensourcetb.org/ | W
http://opensourcepharma.net/

CRICOS 00026A
This email plus any attachments to it are confidential. Any unauthorised
use is strictly prohibited. If you receive this email in error, please
delete it and any attachments.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20160513/74f7b6f0/attachment.html>